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W company is a bio-pharmaceutical enterprise which  integrates R&D、
manufacturing and sales。It takes innovative R&D as the core competitiveness. Along 
with growing demand for drugs in China and more attention was paid to innovative 
drugs, W company put more and more innovative drugs into clinical trials. The clinical 
research (CR) Department of W company is responsible for the clinical trial 
management, and was put forward higher requirements in the aspects of professional 
construction management , personnel training. However, the current level of its 
performance management is low, and the department work is behind with the strategic 
goal of the enterprise. Because the performance evaluation methods can not meet the 
growing demand of enterprises management, so it is time to design a set of scientific 
and effective performance management system to adapt to the development of W 
company. 
In this paper, the first two chapters introduce the research background, significance, 
ideas and theories about performance management. The third chapter introduces the 
characteristics of the CR department and the staff, analysis the existing performance 
management problems. The fourth chapter puts forward improved methods of the 
performance management, and takes CRA as an example to explain how to set up key 
performance indicators (KPI) base on the company's strategy. Then I illustrate the 
performance management process, including performance planning, performance 
implementation and management, performance assessment, performance feedback and 
application of performance appraisal results. Finally, the paper summarized the the 
expected effect and problems of the improved performance management system. 
This paper based upon performance management theory to analyze the 
performance management problems of W company CR department, and wish to design 
a more scientific and effective performance management system which suitable for the 
W company. I hope this performance management based on KPI can improve the 
performance management level of W company CR department, and provide reference 
for the vast pharmaceutical enterprises. 
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健康志愿者或病人作为受试对象，受试例数为 20 至 30 例；Ⅱ期临床试验是
初步评价药物对目标适应症患者的治疗作用和安全性，试验组和对照组的受试
例数均不可低于 100 例；Ⅲ期临床试验是进一步验证药物对目标适应症患者的
治疗作用和安全性，试验组例数一般不低于 300 例[1]。 
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